Ambee Pharmaceuticals PLC (DSE: AMBEEPHA)

Ambee Pharmaceuticals Revenue

Ambee Pharmaceuticals had revenue of 71.47M BDT in the quarter ending September 30, 2024, with 22.01% growth. This brings the company's revenue in the last twelve months to 232.20M, up 11.78% year-over-year. In the fiscal year ending June 30, 2024, Ambee Pharmaceuticals had annual revenue of 219.30M with 10.71% growth.

• Revenue (ttm): 232.20M
• Revenue Growth: +11.78%
• P/S Ratio: 7.31
• Revenue / Employee: 438.94K
• Employees: 477
• Market Cap: 1.70B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	219.30M	21.21M	10.71%
Jun 30, 2023	198.10M	17.10M	9.45%
Jun 30, 2022	180.99M	82.02M	82.86%
Jun 30, 2021	98.98M	-186.33M	-65.31%
Jun 30, 2020	285.30M	-35.92M	-11.18%